{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:37:40Z","timestamp":1792197460968,"version":"4.4.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.diagmicrobio.2009.02.007","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T08:40:41Z","timestamp":1238748041000},"page":"146-151","source":"Crossref","is-referenced-by-count":22,"title":["Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time\u2013kill methodology"],"prefix":"10.1016","volume":"64","author":[{"given":"Mara C.S.M.","family":"Pappalardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Walderez","family":"Szeszs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana B.","family":"Baceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas X.","family":"Bonfietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia U.","family":"Purisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s A.","family":"Baez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia S.C.","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/432073","article-title":"Baseline correlation and comparative kinetics of cerebrospinal colony-forming unit counts and antigen titers in cryptococcal meningitis","volume":"192","author":"Brouwer","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0732-8893(00)00173-5","article-title":"A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time\u2013kill methodology","volume":"38","author":"Burgess","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib3","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1128\/AAC.01520-05","article-title":"Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis","volume":"50","author":"Dannaoui","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib4","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1099\/jmm.0.46789-0","article-title":"Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates","volume":"55","author":"Dias","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1128\/AAC.46.2.578-581.2002","article-title":"Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, E-test, and time\u2013kill methods","volume":"46","author":"Ernst","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib6","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1469-0691.2008.02021.x","article-title":"In vitro susceptibility of Cryptococcus gattii clinical isolates","volume":"14","author":"Gomez-Lopez","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib7","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","volume":"30","author":"Kaplan","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0732-8893(01)00297-8","article-title":"Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time\u2013kill methodology","volume":"41","author":"Keele","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib9","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1128\/AAC.41.6.1392","article-title":"Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans","volume":"41","author":"Klepser","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/AAC.42.5.1207","article-title":"Influence of test conditions on antifungal time\u2013kill curve results: proposal for standardized methods","volume":"42","author":"Klepser","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib11","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1128\/AAC.44.7.1917-1920.2000","article-title":"Evaluation of voriconazole pharmacodynamics using time\u2013kill methodology","volume":"44","author":"Klepser","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib12","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1128\/AAC.49.8.3297-3301.2005","article-title":"Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans","volume":"49","author":"Larsen","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib14","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JCM.36.10.2817-2822.1998","article-title":"Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies","volume":"36","author":"Lozano-Chiu","year":"1998","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib15","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1590\/S0074-02762007000700001","article-title":"Molecular diversity of serial Cryptococcus neoformans isolates from AIDS patients in the city of S\u00e3o Paulo, Brazil","volume":"102","author":"Martins","year":"2007","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib16","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1086\/368091","article-title":"The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1999\u20132000","volume":"36","author":"Mirza","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1439-0507.2003.00872.x","article-title":"Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques","volume":"46","author":"Moraes","year":"2003","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib18","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard -","author":"National Committee for Clinical Laboratory Standards (NCCLS)","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diagmicrobio.2004.08.013","article-title":"Evaluation of Mycograb, amphotericin B, caspofungin, and fluconazole in combination against Cryptococcus neoformans by checkerboard and time\u2013kill methodologies","volume":"51","author":"Nooney","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1590\/S0036-46652003000600001","article-title":"Cryptococcosis: a review of the Brazilian experience for the disease","volume":"45","author":"Pappalardo","year":"2003","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib21","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/01.aids.0000287549.79368.33","article-title":"AIDS-associated central nervous system cryptococcosis: a Brazilian case study. Research Letters","volume":"21","author":"Pappalardo","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0891-5520(05)70192-6","article-title":"Antifungal susceptibility testing. New technology and clinical applications","volume":"15","author":"Pfaller","year":"2001","journal-title":"Infect. Dis. Clin. North Am."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1128\/AAC.39.4.906","article-title":"Detection of amphotericin B-resistant Candida isolates in a broth-based system","volume":"39","author":"Rex","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","article-title":"Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro\u2013in vivo correlation data for fluconazole, itraconazole, and C infections","volume":"24","author":"Rex","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/45.2.239","article-title":"In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy","volume":"45","author":"Rodero","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/mmy.38.3.201.207","article-title":"Time\u2013kill curves for Cryptococcus neoformans isolated from patients with AIDS","volume":"38","author":"Rodero","year":"2000","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1086\/313757","article-title":"Practice guidelines for the management of cryptococcal disease","volume":"30","author":"Saag","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: multicenter Aids cohort study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib29","first-page":"119","article-title":"Antifungal drug resistance in pathogenic fungi","volume":"36","author":"Vanden Bossche","year":"1998","journal-title":"Med. Mycol."},{"key":"10.1016\/j.diagmicrobio.2009.02.007_bib30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jac\/42.3.321","article-title":"Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans","volume":"42","author":"Warnock","year":"1998","journal-title":"J. Antimicrob. Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309000649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889309000649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:57:39Z","timestamp":1589705859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889309000649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0732889309000649"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2009.02.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}